MedTrace Logo

Adding Neurocognitive Component to Balance Test

NCT06827483 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-05-07

No results posted yet for this study

Summary

By introducing BlazePods as a neurocognitive addition to the YBT, this study aims to determine whether this addition impacts balance performance and/or reach distances between the operative and non-operative limbs of patients recovering from ACL reconstruction. Findings will contribute to optimizing return-to-sport protocols and enhancing late-stage rehabilitation program designs.

Conditions

  • Anterior Cruciate Ligament Injuries

Interventions

OTHER

Neurocognitive Component

A neurocognitive component will be added to the Y Balance Test

Sponsors & Collaborators

Principal Investigators

  • Robert Tisherman, MD · Duke University

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-14
Primary Completion
2027-06-01
Completion
2027-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06827483 on ClinicalTrials.gov